Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Abilify
Active Ingredient: Aripiprazole 2mg
Dosage Form: Tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturers: Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product: Abilify
Active Ingredient: Aripiprazole 5mg
Dosage Form: Tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturers: Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product: Abilify
Active Ingredient: Aripiprazole 10mg
Dosage Form: Tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturers: Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product: Abilify
Active Ingredient: Aripiprazole 15mg
Dosage Form: Tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturers: Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product: Abilify
Active Ingredient: Aripiprazole 20mg
Dosage Form: Tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturers: Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product: Abilify
Active Ingredient: Aripiprazole 30mg
Dosage Form: Tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturers: Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product: Abilify ODT
Active Ingredient: Aripiprazole 10mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Product: Abilify ODT
Active Ingredient: Aripiprazole 15mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Product: Abilify ODT
Active Ingredient: Aripiprazole 20mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Product: Abilify ODT
Active Ingredient: Aripiprazole 30mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Product: Nicorette Inhaler
Active Ingredient: Nicotine 15mg
Dosage Form: Volatile liquid for inhalation
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: McNeil AB, Helsingborg, Sweden
Product: Tykerb
Active Ingredient: Lapatinib ditosilate 405mg equivalent to 250mg lapatinib free base
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Glaxo Operations UK Limited (t/a Glaxo Wellcome Operations), Hertfordshire, United Kingdom
Dated this 3rd day of September 2010.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).